Comment from Insmed Incorporated

Summary: Insmed Incorporated expresses support for the draft guidance on the Common Technical Document for the Registration of Pharmaceuticals for Human Use: Quality. The company proposes several specific refinements and additions to the guidance to improve consistency, clarity, and reduce redundant post-approval filing burdens.